Content of circulating endothelial progenitor cells in patients with chronic ischemic heart failure with preserved left ventricular ejection fraction

Kardiologiya

Volumn 55, Issue 1, 2015, Pages 14-22

  Berezin, A E ^a   Kremzer, A A ^a  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Chronic heart failure; Circulating endothelial progenitor cells; Ischemic heart disease

Indexed keywords

ANGIOGENESIS; BLOOD; CELLULAR IMMUNITY; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ENDOTHELIAL PROGENITOR CELLS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84926169308     PISSN: 00229040     EISSN: 24125660     Source Type: Journal    
DOI: 10.18565/cardio.2015.1.14-22     Document Type: Article

References (36)

1. Ravi S., Caves J. M., Martinez A. W. et al. Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury. Biomaterials 2012;33:7736-7745.
2. Chen Z., Zhang F. R., Tao Q. M. et al. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004;107:273-280.
3. Hill J. M., Zalos G., Halcox J. P. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
4. Morishita T., Uzui H., Nakano A. et al. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb 2012;19:149-158.
5. Alba A. C., Lalonde S. D., Rao V. et al. Circulating proangiogenic progenitor cells independently predict functional capacity in heart failure patients. Can J Cardiol 2013;29:664-671.
6. Schmidt-Lucke C, Rossig L., Fichtlscherer S. et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.
7. Hirschi K. K., Ingram D. A., Yoder M. C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
8. Fadini G. P., Baesso I., Albiero M. et al. Atherosclerosis 2008;197:496-503.
9. Hill J. M., Zalos G., Halcox J. P. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
10. Adams V., Lenk K., Linke A. et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exerciseinduced ischemia. Arterioscler Thromb Vasc Biol 2004;24:684-690.
11. Banerjee S., Brilakis E., Zhang S. et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006;189:70-75.
12. Vasa M., Fichtlscherer S., Adler K. et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-2890.
13. Tamura H., Okamoto S., Iwatsuki K. et al. In vivo differentiation of stem cells in the aorta-gonad-mesonephros region of mouse embryo and adult bone marrow. Exp Hematol 2002;30:957-966.
14. Bozdag-Turan I., Turan R. G., Paranskaya L. et al. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease. J Transl Med 2012;10:143.
15. Liew A., Barry F., O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006;28:261-270.
16. Padfield G. J., Tura-Ceide O., Freyer E. et al. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart 2013;99:791-798.
17. McMurray J. J., Adamopoulos S., Anker S. D. et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
18. Bluemke D. A., Achenbach S., Budoff M. et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 2008;118:586-606.
19. Agatston A. S., Janowitz W. R. Ultrafast computed tomography in coronary screening. Circulation 1994;89:1908-1909.
20. Budoff M. J., Achenbach S., Blumenthal R. S. et al. American Heart Association Committee on Cardiovascular Imaging and Intervention; Council on Clinical Cardiology. Circulation 2006;114:1761-1791.
21. Schiller N. B., Shah P. M., Crawford M. et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
22. Pellerin D., Sharma R., Elliott P. et al. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003;89:9-17.
23. Levey A. S., Stevens L. A., Schmid C. H. et al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med 2009;150:604-612.
24. Tung J. W., Parks D. R., Moore W. A. et al. New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol 2004;110(3):277-283.
25. Singh N., Van Craeyveld E., Tjwa M. et al. Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy. J Am Coll Cardiol 2012;60:324-331.
26. Morishita T., Uzui H., Nakano A. et al. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb 2012;19:149-158.
27. Bakogiannis C, Tousoulis D., Androulakis E. et al. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. Curr Med Chem 2012;19:2597-2604.
28. Werner N., Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler. Thromb Vasc Biol 2006;26:257-266.
29. Liew A., Barry F., O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006;28:261-270.
30. Padfield G. J., Tura-Ceide O., Freyer E. et al. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart 2013;99(11):791-798.
31. Peichev M., Naiyer A. J., Pereira D. et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958.
32. Qian C, Schoemaker R. G., Van Gilst W. H., Roks, A. J. M. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Clin Sci 2009;116:301-314.
33. Dimmeler S., Aicher A., Vasa M. et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-397.
34. Fadini G. P., Maruyama S., Ozaki T. et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS ONE 2010;5:e11488.
35. Alba A. C., Lalonde S. D., Rao V. et al. Circulating Proangiogenic Progenitor Cells Independently Predict Functional Capacity in Heart Failure Patients. Can J Cardiol 2013;29(6):664-671.
36. Adams V., Lenk K., Linke A. et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exerciseinduced ischemia. Arterioscler Thromb Vasc Biol 2004;24:684-690.